Diagnostic tests with algorithms seem to slow review periods on average. Share this Image On Your Site <p><strong>Please include attribution to https://amplion.wpengine.com/biomarker-trends with this graphic.</strong><br /><br /><a...
As we have previously reported in this blog, innovation is not a major focus for many of the largest diagnostics companies. With but a few exceptions, the focus for the largest companies tends to be on selling instrumentation and on developing “me-too” tests, which...